Manulife (Manufacturers Life Insurance)’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-37,386
| Closed | -$6.72M | – | 4441 |
|
|
2017
Q3 | $6.72M | Sell |
37,386
-387
| -1% | -$53.9K | 0.01% | 1028 |
|
|
2017
Q2 | $3.92M | Buy |
37,773
+7,028
| +23% | +$573K | ﹤0.01% | 1271 |
|
|
2017
Q1 | $2.41M | Buy |
30,745
+3,710
| +14% | +$229K | ﹤0.01% | 1375 |
|
|
2016
Q4 | $1.21M | Buy |
27,035
+134
| +0.5% | +$6.57K | ﹤0.01% | 1585 |
|
|
2016
Q3 | $1.5M | Buy |
26,901
+88
| +0.3% | +$4.9K | ﹤0.01% | 1456 |
|
|
2016
Q2 | $1.34M | Buy |
26,813
+6,394
| +31% | +$314K | ﹤0.01% | 1470 |
|
|
2016
Q1 | $903K | Buy |
20,419
+1,185
| +6% | +$57.4K | ﹤0.01% | 1664 |
|
|
2015
Q4 | $1.19K | Buy |
19,234
+181
| +0.9% | +$12.7K | ﹤0.01% | 1549 |
|
|
2015
Q3 | $1.06K | Buy |
19,053
+469
| +3% | +$29.5K | ﹤0.01% | 1571 |
|
|
2015
Q2 | $1.13K | Buy |
18,584
+11,598
| +166% | +$662K | ﹤0.01% | 1622 |
|
|
2015
Q1 | $403 | Buy |
6,986
+498
| +8% | +$33.4K | ﹤0.01% | 2215 |
|
|
2014
Q4 | $374 | Buy |
6,488
+6,283
| +3,065% | +$265K | ﹤0.01% | 2179 |
|
|
2014
Q3 | $6 | Buy |
+205
| New | +$5.07K | ﹤0.01% | 3608 |
|
Manulife (Manufacturers Life Insurance)'s KITE Position: Q4 2017 in Review
Manulife (Manufacturers Life Insurance) sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 37,386 shares — an estimated $6.72M sold.
Manulife (Manufacturers Life Insurance) first reported a position in KITE in Q3 2014 and held it in 13 quarters. The position peaked at $6.72M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.
- Manulife (Manufacturers Life Insurance) reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 37,386 Kite Pharma, Inc. shares in Q4 2017, an estimated $6.72M.
- Manulife (Manufacturers Life Insurance) first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 13 quarters.
- Manulife (Manufacturers Life Insurance)'s Kite Pharma, Inc. position peaked at $6.72M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2017, filed 8 Feb 2018.